TY  - GEN 
AU  - Ureña Paniego, Clara Amanda
AU  - Sanabria de la Torre, Raquel
AU  - Arias Santiago, Salvador
AU  - Montero Vílchez, Trinidad
PY  - 2025
UR  - https://hdl.handle.net/10481/108245
AB  - Background: Cyclosporine (CSA) is a fast-acting systemic immunosuppressant frequently
used in moderate-to-severe atopic dermatitis (AD), but its long-term use is limited by
toxicity. AD affects as many as 20% of children and nearly 10% of adults...
LA  - eng
PB  - MDPI
KW  - Atopic dermatitis
KW  - Tralokinumab
KW  - Cyclosporine
TI  - Transitioning from Cyclosporine to Tralokinumab in Moderate-to-Severe Atopic Dermatitis: A Prospective Real-World Comparison of Direct Switch vs. Short Overlap
DO  - 10.3390/jpm15110515
ER  -